Association study between the CX3CR1 gene and asthma

被引:0
|
作者
K Tremblay
M Lemire
V Provost
T Pastinen
Y Renaud
A J Sandford
M Laviolette
T J Hudson
C Laprise
机构
[1] University of Montreal Community Genomic Medicine Centre,Department of Medicine
[2] Chicoutimi University Hospital,Department of Medicine
[3] Hôpital Laval,Department of Medicine and Human Genetics
[4] Institut universitaire de cardiologie et de pneumologie de l'Université Laval,Département des Sciences Fondamentales
[5] McGill University and Genome Québec Innovation Centre,undefined
[6] James Hogg iCapture Centre,undefined
[7] University of British Columbia,undefined
[8] Université du Québec à Chicoutimi,undefined
来源
Genes & Immunity | 2006年 / 7卷
关键词
association study; asthma; CX3CR1; polymorphisms; haplotypic analyses;
D O I
暂无
中图分类号
学科分类号
摘要
CX3CR1, a fractalkine receptor, mediates cell-adhesive and migratory functions in inflammation. Based on CX3CR1 expression observed in bronchial tissues of asthmatic subjects, we hypothesized that genetic variation at this locus may affect susceptibility to asthma. We carried out an association study and a haplotypic analysis with selected polymorphisms of the CX3CR1 in a familial asthmatic sample from a founder population. Genetic analyses performed by FBAT software showed five CX3CR1 single nucleotide polymorphisms (rs938203, rs2669849, rs1050592, T280M and V249I) with significant associations between their common alleles and asthma (P<0.004) in a dominant model. A haplotype formed with common alleles of rs1050592, T280M and V249I is also overtransmitted in asthmatic subjects (P=0.005) under a dominant model. The associations of V249I and rs2669849 have been validated in an independent case–control sample. For V249I, odds ratios (OR) are 2.16 (common homozygous) and 2.11 (heterozygous) in dominant model (P=0.031). For rs2669849, OR are 2.75 (common homozygous) and 1.86 (heterozygous) in additive model (P=0.007) and dominant model (P=0.059). These results suggest an asthma protective effect of the minor alleles in healthy control carriers. Further functional studies of CX3CR1 are needed to document its role in the pathophysiology of asthma.
引用
收藏
页码:632 / 639
页数:7
相关论文
共 50 条
  • [21] CX3CR1 as a target for airways inflammation
    Doggrell, Sheila A.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2011, 15 (09) : 1139 - 1142
  • [22] Association between polymorphisms in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis
    Halcox, JPJ
    McDermott, DH
    Merrell, MN
    Epstein, N
    Murphy, PM
    Quyyumi, AA
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 302A - 302A
  • [23] Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis
    McDermott, DH
    Halcox, JPJ
    Schenke, WH
    Waclawiw, MA
    Merrell, MN
    Epstein, N
    Quyyumi, AA
    Murphy, PM
    CIRCULATION RESEARCH, 2001, 89 (05) : 401 - 407
  • [24] Regulation of microglia neurotoxicity by CX3CR1 and CX3CL1
    Cardona, AE
    Huang, DR
    Sasse, ME
    Kidd, G
    Lira, S
    Cook, D
    Jung, S
    Littman, D
    Ransohoff, R
    FASEB JOURNAL, 2005, 19 (04): : A940 - A940
  • [25] The effects of polymorphisms in the CX3CR1 gene on the development of canine hip dysplasia
    Atalay, Sertac
    Kok, Suleyman
    TURKISH JOURNAL OF VETERINARY & ANIMAL SCIENCES, 2022, 46 (01): : 74 - 87
  • [26] CX3CR1 Is a Modifying Gene of Survival and Progression in Amyotrophic Lateral Sclerosis
    Lopez-Lopez, Alan
    Gamez, Josep
    Syriani, Emilio
    Morales, Miguel
    Salvado, Maria
    Rodriguez, Manuel J.
    Mahy, Nicole
    Vidal-Taboada, Jose M.
    PLOS ONE, 2014, 9 (05):
  • [27] The polymorphisms of CX3CR1 gene influence ALS survival in an Italian population-based study
    Moglia, Cristina
    Calvo, Andrea
    Canosa, Antonio
    Brunetti, Maura
    Traynor, Bryan J.
    Barberis, Marco
    Mora, Gabriele
    Chio, Adriano
    NEUROLOGY, 2017, 88
  • [28] Lack of association between the functional CX3CR1 polymorphism V249I and hepatocellular carcinoma
    Mühlbauer, M
    Ringel, S
    Hartmann, A
    Lallinger, G
    Weiss, TS
    Gäbele, E
    Wünsch, PH
    Schölmerich, J
    Hellerbrand, C
    ONCOLOGY REPORTS, 2005, 13 (05) : 957 - 963
  • [29] Chemokines and atherosclerosis: focus on the CX3CL1/CX3CR1 pathway
    Stavros Apostolakis
    Demetrios Spandidos
    Acta Pharmacologica Sinica, 2013, 34 : 1251 - 1256
  • [30] Functional analysis of the chemokine receptor CX3CR1
    Chen, YM
    Green, S
    Quehenberger, O
    FASEB JOURNAL, 2005, 19 (05): : A1419 - A1419